Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (28)

2024

  1. Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

    British Journal of Surgery, Vol. 111, Núm. 1

  2. Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago

    World Journal of Emergency Surgery, Vol. 19, Núm. 1

2023

  1. Risk factors for anastomotic leakage and postoperative outcomes after total and subtotal colectomy: A nationwide retrospective cohort study (RIALTCOT Study Collaborative Group)

    Colorectal Disease, Vol. 25, Núm. 3, pp. 420-430

  2. Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients

    British Journal of Surgery, Vol. 110, Núm. 12, pp. 1863-1876

2021

  1. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  2. Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study

    Journal of Clinical Anesthesia, Vol. 74

  3. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  4. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749

2020

  1. Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial

    Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25

2003

  1. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer

    International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790

1997

  1. Prediction of recurrence by quantification of p185(neu) protein in non-small cell lung cancer tissue

    British Journal of Cancer, Vol. 75, Núm. 5, pp. 684-689

  2. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: Rationale of sequential processing of frozen and paraffin-embedded tissue

    World Journal of Surgery, Vol. 21, Núm. 3, pp. 323-329

1996

  1. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma

    Cancer, Vol. 77, Núm. 6, pp. 1066-1072

  2. Colorectal cancer: Has its diagnosis improved in the last decade?

    Revista Espanola de Enfermedades Digestivas, Vol. 88, Núm. 1, pp. 26-28

  3. Escherichia coli resistance to amoxicillin and co-amoxiclav in a community with high aminopenicillin consumption rate

    Revista Espanola de Quimioterapia

  4. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer

    British Journal of Cancer, Vol. 73, Núm. 10, pp. 1248-1254

1995

  1. Valor pronóstico de variables predictivas comunes en el cáncer de recto.

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 87, Núm. 3, pp. 205-210

1994

  1. CONCEPTOS ACTUALES SOBRE LA UTILIZACION DE MARCADORES TUMORALES EN EL CANCER DE PULMON

    Revisiones en Cancer, Vol. 8, Núm. 3, pp. 88-93

  2. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma

    Anticancer Research, Vol. 14, Núm. 6 B, pp. 2819-2825

  3. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non‐small cell lung cancer

    Cancer, Vol. 73, Núm. 9, pp. 2305-2311